DOCSLIB.ORG

Neurological Sciences LE JOURNAL CANADIEN DES Sciences Neurologiques

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neurological Sciences LE JOURNAL CANADIEN DES Sciences Neurologiques Volume 26 Number 4 November 1999 THE CANADIAN JOURNAL OF Neurological Sciences LE JOURNAL CANADIEN DES Sciences Neurologiques AN INTERNATIONAL JOURNAL / UN JOURNAL INTERNATIONAL REVIEW ARTICLE 255 EEG in Epilepsy: Current Perspectives M. Sundaram, R.M. Sadler, G.B. Young and N. Pillay ORIGINAL ARTICLES 263 Burden of Epilepsy: The Ontario Health Survey Samuel Wiebe, David R. Bellhouse, Christine Fallahay, Michael Eliasziw 271 Topiramate in Intractable Childhood Onset Epilepsy - A Cautionary Note J.M. Dooley, P.R. Cornfield, E. Smith, P. Langevin, G. Ronen 21A Consensus Statement of the Canadian MS Clinics Network on: The Use of Disease Modifying Agents in Multiple Sclerosis Joel Oger and Mark Freedman Dr. Charles G. Drake 1920-1998 276 Treatment with Interferon Beta- lb Improves Quality of Life in Multiple Sclerosis G.P. Rice, J. Oger, P. Duquette, G.S. Francis, M. Belanger, S. Laplante, J.F. Grenier 283 Responsiveness of the Scripps Neurologic Rating Scale During a Multiple Sclerosis Clinical Trial James A. Koziol, Adridna Lucero, Jack C. Sipe, John S. Romine, Ernest Beutler 290 MR Characteristics of Malignant Spinal Cord Astrocytomas in Children Abhaya V. Kulkarni, Derek C. Armstrong and James M. Drake 294 EMG Related Anxiety and Pain: A Prospective Study Mohammed M.S. Jan, Murray Schwartz, and Timothy J. Benstead EXPERIMENTAL NEUROSCIENCES 298 Biphasic Opening of the Blood-Brain Barrier Following Transient Focal Ischemia: Effects of Hypothermia Z. Gao Huang, Dong Xue, Edward Preston, Hasneen Karbalai, Alastair M. Buchan 305 Mevalonate Prevents Lovastatin-Induced Apoptosis in Medulloblastoma Cell Lines Wei Wang and Robert J.B. Macaulay Neuroimaging Highlight NEUROIMAGING HIGHLIGHT 311 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) J.N. Scott, L. Metz, W.Y.Hu andM. Hudon CASE REPORTS 313 Utility of a Moveable 1.5 Tesla Intraoperative MR Imaging System: Case Report Taro Kaibara, John K. Saunders and Garnette R. Sutherland 317 Reversible Paraneoplastic Encephalomyelitis Associated with a Benign Ovarian Teratoma 35th CANADIAN R. Blaine Taylor, Warren Mason, Kester Kong, Richard Wennberg CONGRESS OF 321 Temporal Dermoid Cyst with a Partial Dermal Sinus Tract: A Case Report NEUROLOGICAL Joseph A. Shehadi, Ibrahim A. Alorainy, Karen M. Johnston SCIENCES 325 Acute Quadriplegic Myopathy Unrelated to Steroids or Paralyzing Agents: Quantitative EMG Studies June 13 - 17, 2000 Ahmet Hoke, N.B. Rewcastle and Douglas W. Zochodne Ottawa, Ontario IN MEMORIAM 330 Dr. Charles G. Drake 1920 - 1998 341 Canadian Association of Neuropathologists Abstracts of papers and cases presented at the 39th Annual Meeting SUPPLEMENT 3 SI The Scientific Basis of Migraine Management The official Journal of: The Canadian Neurological Society, The Canadian Neurosurgical Society, The Canadian Society of Clinical Neurophysiologists, The Canadian Association of Child Neurology Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 24 Sep 2021 at 17:13:12, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0317167100050058 <$vv « »<?•«m&« YOU FOR>/ JIPKA.! LEVODORL Using RcQuip in ear!}' disease can sustain symptom control and has been shown to delay the need for ievodopa in the majority of patients (61 of 102) who completed a full 3 year study.M CONTINUED BENEFITS IN ADJUNCT THERAPY. RcQuip allowed a 20% or greater reduction in Ievodopa dose and also increased patients' 'on' time by 20% or more alter 6 months of combination therapy." SPARING LEVODOPA CAN DELAY COMPLICATIONS. Because ReQuip spares Ievodopa in both early and adjunct therapy, it can substantially reduce Ievodopa load for Parkinson's patients. As a result, ReQuip can delay and reduce long-term Ievodopa complications such as dyskinesias, 'on-off' effect and 'wearing off' effect.16 So starting ReQuip today can give Parkinsons patients a brighter outlook for tomorrow. +Mean dosage: 9.7 mg (SD 6.0) RcQuip (n«179), 464.0 rag (SD 266.0) l-dopa (n-89). 95% CI of 0.28, 2.26 Stage 1 or 1.5: 0.43, 3.07 Siage II; 0.04, 0.35 Stage II.5 or III. AMean UPDRS improvement in the non-selegilinc subgroup. Mean dosage: rropinirole 9.0 mg (SD 5.2) ReQuip (n«109), 17.2 mg (SD 8.8) bromocriptine (n.101). j^-X °P' 95% CI of 6.0%. 21.1%. 'Achieved by 28% of ropinirole (n*94) and 11% of placebo (n=54) treated B patients. 95% CI of 1.533, 12.658.' In early thetapy\ nausea (59.9%), dizziness (40.1%) and somnolence (40.1%) CST1 SmithKhne Beecham REQUIP were the most common side effects of ReQuip. Postural hypotension occurred l3ft# Pharma in 6.4% of patients. Thtrapy Jf^^J^ Tag In adjunct therapy with Ievodopa', dyskinesias (33.7%) and nausea (29.8%) were the most common side effects of ReQuip. |PAAB| C^h RIGHT FROM THE START. Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 24 Sep 2021 at 17:13:12, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0317167100050058 For brief prescribing information see pages A-41, A-42 Volume 26 Number 4 November 1999 THE CANADIAN JOURNAL OF Neurological Sciences LE JOURNAL CANADIEN DES Sciences Neurologiques A-39 MESSAGE FROM THE EDITOR CASE REPORTS 313 Utility of a Moveable 1.5 Tesla Intraoperative MR Imaging REVIEW ARTICLE System: Case Report 255 EEG in Epilepsy: Current Perspectives Taw Kaibara, John K. Saunders and Garnette R. Sutherland M. Sundaram, R.M. Sadler, G.B. Young and N. Pillay 317 Reversible Paraneoplastic Encephalomyelitis Associated ORIGINAL ARTICLES with a Benign Ovarian Teratoma R. Blaine Taylor, Warren Mason, Kester Kong, 263 Burden of Epilepsy: The Ontario Health Survey Richard Wennberg Samuel Wiebe, David R. Bellhouse, Christine Fallahay, Michael Eliasziw 321 Temporal Dermoid Cyst with a Partial Dermal Sinus Tract: A Case Report 271 Topiramate in Intractable Childhood Onset Epilepsy - Joseph A. Shehadi, Ibrahim A. Alorainy, Karen M. Johnston A Cautionary Note J.M. Dooley, P.R. Camfleld, E. Smith, P. Langevin, 325 Acute Quadriplegic Myopathy Unrelated to Steroids or G. Ronen Paralyzing Agents: Quantitative EMG Studies Ahmet Hoke, N.B. Rewcastle and Douglas W. Zochodne 274 Consensus Statement of the Canadian MS Clinics Network on: The Use of Disease Modifying Agents in IN MEMORIAM Multiple Sclerosis 330 Dr. Charles G. Drake 1920 - 1998 Joel Oger and Mark Freedman Gary G. Ferguson and Vladimir C. Hachinski 276 Treatment with Interferon Beta-lb Improves Quality of 331 Perspectives from Dr. Charles Drake: Early Training in Toronto Life in Multiple Sclerosis Charles G. Drake G.P. Rice, J. Oger, P. Duquette, G.S. Francis, M. Belanger, S. Laplante, J.F. Grenier 335 Bleeding Aneurysms of the Basilar Artery. Direct Surgical Management in Four Cases 283 Responsiveness of the Scripps Neurologic Rating Scale Charles G Drake (Reprinted from the Journal of During a Multiple Sclerosis Clinical Trial Neurosurgery, 1961) James A. Koziol, Adriana Lucero, Jack C. Sipe, John S. Romine, Ernest Beutler 341 Canadian Association of Neuropathologists Abstracts of papers presented at the 39th Annual Meeting 290 MR Characteristics of Malignant Spinal Cord Astrocytomas in Children 346 Letter to the Editor Abhaya V. Kulkarni, Derek C. Armstrong and 347 Books Received James M. Drake 347 Book Reviews 294 EMG Related Anxiety and Pain: A Prospective Study 352 Notes and Announcements Mohammed M.S. Jan, Murray Schwartz, and Timothy J. Benstead 353 Calendar of Events 354 Index to Volume 26 EXPERIMENTAL NEUROSCIENCES A-6 Call for Abstracts - 35th Canadian 298 Biphasic Opening of the Blood-Brain Barrier Following Congress of Neurological Sciences Transient Focal Ischemia: Effects of Hypothermia Z. Gao Huang, Dong Xue, Edward Preston, A-12 Preliminary Program - 35th Canadian Hasneen Karbalai, Alastair M. Buchan Congress of Neurological Sciences A-20, A-26 1999 Society Prize Announcements 305 Mevalonate Prevents Lovastatin-Induced Apoptosis in Medulloblastoma Cell Lines A-40 Information for Authors Wei Wang and Robert J.B. Macaulay A-18, A-32 25 Years Ago in the Canadian Journal of Neurological Sciences NEUROIMAGING HIGHLIGHT A-73 Advertisers Index 311 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) SUPPLEMENT 3 J.N. Scott, L. Metz, W.Y.Hu andM. Hudon S1-S43 The Scientific Basis of Migraine Management Downloaded from https://www.cambridge.org/core. IP address: 170.106.35.93, on 24 Sep 2021A-l at 17:13:12, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0317167100050058 Volume 26 Number 4 November 1999 THE CANADIAN JOURNAL OF Neurological Sciences LE JOURNAL CANADIEN DES Sciences Neurologiques Editor/Redacteur en chef The official journal of: / La Revue offlcielle de: Douglas W. Zochodne CALGARY, AB The Canadian Neurological Society La Societe Canadienne de Neurologie Associate Editors/Redacteurs associes The Canadian Neurosurgical Society Laurence E. Becker TORONTO, ON La Societe Canadienne de Neurochirurgie The Canadian Society of Clinical Neurophysiologists Andres M. Lozano TORONTO, ON La Societe Canadienne de Neurophysiologie Clinique The Canadian Association of Child Neurology Past Editors L'Association Canadienne de Neurologie Pediatrique James A. Sharpe TORONTO, ON The permanent secretariat for the four societies and the Canadian Robert G. Lee CALGARY, AB Congress of Neurological Sciences is at/ Robert T. Ross WINNIPEG, MB Le secretariat des quatre associations et du Congres Canadien des Sciences Neurologiques est situe en permanence a: (founding editor) 810, 906 - 12 Avenue S.W., Calgary, AB Canada T2R 1K7 Editorial Board/Conseil Scientifique The Canadian Journal of Neurological Sciences is published quarterly. The Harold P. Adams IOWA CITY, IA, USA annual subscription rate is $70 for members; $77 for non-members in Canada; Jack P. Antel MONTREAL, QC $88 for USA and elsewhere. Residents.
Load more

Recommended publications
  • Revista Română De Cardiologie
    REVISTA ROMÂNĂ DE CARDIOLOGIE ROMANIAN HEART JOURNAL Vol. XXI, Nr. 2, 2006 REVISTA ROMÂNĂ DE CARDIOLOGIE REVISTA SOCIETĂŢII ROMÂNE DE CARDIOLOGIE COLECTIVUL DE REDACŢIE Redactor șef: Redactor șef adjunct: Prof. Dr. Eduard Apetrei Prof. Dr. Carmen Ginghină Redactori: Redactori asociaţi: Prof. Dr. Radu Căpâlneanu Dr. Mihaela Rugină Prof. Dr. Cezar Macarie Dr. Ruxandra Jurcuţ Dr. Bogdan A. Popescu Dr. Costel Matei Redactor fondator Prof. Dr. C. Carp Colegiul de redacţie: Prof. Dr. E. Grosu – R. Moldova Prof. Dr. Ion V. Bruckner – București Prof. Dr. Alexandru Ioan – București Prof. Dr. Alexandru Câmpeanu – București Prof. Dr. Dan Dominic lonescu – Craiova Prof. Dr. Mircea Cinteză – București Dr. Matei Iliescu – București Dr. Radu Ciudin – București Prof. Dr. Ioan Maniţiu – Sibiu Prof. Dr. Radu Cristodorescu – Timișoara Prof. Dr. Gerald A. Maurer – Austria Prof. Dr. D.V. Cokinos – Grecia Dr. Șerban Mihăileanu – Franţa Dr. Dan Deleanu – București Prof. Dr. Nour Olinic – Cluj Napoca Prof. Dr. Genevieve Derumeaux – Franţa Prof. Dr. Fausto Pinto – Portugalia Prof. Dr. Doina Dimulescu – București Prof. Dr. Mariana Rădoi – Brașov Prof. Dr. Maria Dorobanţu – București Prof. Dr. Willem J. Remme – Olanda Prof. Dr. Ștefan Iosif Drăgulescu – Timișoara Dr. Doina Rogozea – București Prof. Dr. Guy Fontaine – Franţa Prof. Dr. Michal Tendera – Polonia Prof. Dr. Bradu Fotiade – București Prof. Dr. Ion Ţintoiu – București Prof. Dr. Alan Fraser – Anglia Prof. Dr. Panagiotis Vardas – Grecia Prof. Dr. Mihai Gheorghiade – USA Conf. Dr. Dragoș Vinereanu – București Prof. Dr. George Georgescu – Iași Prof. Dr. Marius Vintilă – București Prof. Dr. Leonida Gherasim – București Prof. Dr. Dumitru Zdrenghea – Cluj Napoca Redactor de număr: Dr. Mihaela Rugină 84 CUPRINS VOL. XXI, nr.
    [Show full text]
  • On the Front Lines of Mental Health
    WINTER 2014 UNIVERSITY OF TORONTO MEDICAL ALUMNI ASSOCIATION MAGAZINE MAAMATTERS ON THE FRONT LINES OF MENTAL HEALTH ConvoCation 2014 • FivE DECaDES DiFFEREnt? TO COME DEAN’S MESSAGE Dr. CaTharine WhiTesiDe (1975) A farewell message The Medical Alumni Association (MAA) to provide opportunities to help build at the University of Toronto is one of our and sustain this valued relationship. most important organizations for the When students and trainees enter our ongoing and future success of our medical MD and postgraduate programs, we school. As I complete my tenure as the welcome them into the U of T medical Dean of Medicine and look back over my school family and make a tremendous years closely associated with the MAA, I am effort enabling them to fulfill their HY P very proud of the dedication and accom- potential. Once they graduate they should RA G plishments of our alumni and the MAA feel part of our extended family that now Board. Last year the Faculty established reaches into every aspect of the Canadian PHOTO L E three alumni awards, including the Alumni health system and beyond. We must NN O D Volunteer Award, the Lifetime Achievement provide support for their continuing Award and the Rising Star Award. The professional development, access to rapidly HY: MAC HY: P MAA also recognizes alumni contributions expanding knowledge and its application, RA G through awards and scholarships. and we must welcome their engagement It is so important that we recognize in the mentoring and teaching of our PHOTO alumni who have made an impact through students and trainees.
    [Show full text]
  • Killam Prizes | Prix Killam
    Killam Prizes | Prix Killam Year | Winners | University | Discipline Année Gagnants Université 2021 Michel Bouvier Université de Montréal Health Sciences | sciences de la santé Stephen R. Gill York University Social Sciences | sciences sociales Gilbert Laporte HEC Montréal Engineering | génie Arthur Ripstein University of Toronto Humanities | sciences humaines Douglas Stephan University of Toronto Natural Sciences | sciences de la nature 2020 Cecilia Benoit University of Victoria Social Sciences | sciences sociales Sarah Carter University of Alberta Humanities | sciences humaines Alan Evans Montreal Neurological Institute Health Sciences | sciences de la santé Ted Sargent University of Toronto Engineering | génie Barbara Sherwood Lollar University of Toronto Natural Sciences | sciences de la nature 2019 Yoshua Bengio Université de Montréal Natural Sciences | sciences de la nature André Blais Université de Montréal Social Sciences | sciences sociales Keith W. Hipel University of Waterloo Engineering | génie Stephen W. Scherer University of Toronto Health Sciences | sciences de la santé Lynne Viola University of Toronto Humanities | sciences humaines 2018 André Gaudreault Université de Montréal Humanities | sciences humaines Vladimir Hachinski Western University Health Sciences | sciences de la santé Walter Herzog University of Calgary Engineering | génie James Pinfold University of Alberta Natural Sciences | sciences de la nature Janet Werker University of British Columbia Social Sciences | sciences sociales Canada Council for the Arts
    [Show full text]
  • News Release
    NEWS RELEASE: June 14, 2005 Health care leaders create Canada’s first national health advisory body The Canadian Academy of Health Sciences will give Government and the public comprehensive expertise and advice on health issues EDMONTON - When the President of the United States wants advice on a public health issue, he calls the United States’ National Academies. When the Prime Minister of Great Britain wants to seek similar counsel, he usually turns to the Royal Society of Britain. But when the Prime Minister of Canada wants similar advice, who does he call? Well, that’s not always entirely clear, given the more narrowly defined mandates of many Canadian organizations. Now, however, owing to a recent initiative by a group of leading health care leaders and researchers, the Prime Minister will be able to call the Canadian Academy of Health Sciences (CAHS), recently created to: • Develop informed, strategic assessments on urgent health issues; • Inform public policy on these issues; • Enhance Canada’s readiness to deal with global health issues; and, • Provide a recognized and authoritative Canadian health science voice internationally. According to one of the Academy’s key organizers, the establishment of the Academy is long over due—and all the more pressing given the potential global health threats to Canadians, most recently exemplified by the SARS threat. “Ask Canadians what they care about most, and they answer unequivocally: ‘health,’” explains University of Alberta Professor of Medicine Paul Armstrong, CAHS’s first president. “It makes sense, therefore, that Canada should have an organization that government—and Canadians—can turn to for sound, impartial advice and research on pressing health issues.” The organization will also have an international role to play, representing Canada’s interests abroad and working closely with other nations’ parallel agencies.
    [Show full text]
  • Concomitant Vascular and Neurodegenerative Pathologies Double the Risk of Dementia
    Alzheimer’s & Dementia - (2017) 1-9 Featured Article Concomitant vascular and neurodegenerative pathologies double the risk of dementia Mahmoud Reza Azarpazhooha,b,c,1, Abolfazl Avanb,d,1, Lauren E. Ciprianoc,e, David G. Munozf, Luciano A. Sposatoa,c,g,h, Vladimir Hachinskia,c,* aDepartment of Clinical Neurological Sciences, Western University, London, Ontario, Canada bDepartment of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran cDepartment of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada dDepartment of Neurology, Academic Medical Center, Amsterdam, The Netherlands eIvey Business School, Western University, London, Ontario, Canada fDepartment of Pathology and Laboratory Medicine, University of Toronto & Department of Laboratory Medicine, and Keenan Research Centre for Biomedical Research, The Li Ka Shing Knowledge Institute, St Michael’s Hospital Toronto, Ontario, Canada gStroke, Dementia and Heart Disease Laboratory, Western University, London, Ontario, Canada hDepartment of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada Abstract Introduction: The relative contributions of vascular and degenerative pathology to dementia are un- known. We aim to quantify the proportion of dementia explained by potentially preventable vascular lesions. Methods: We systematically searched for population-based cohorts before February 2017 reporting clinicopathological data for individuals with and without dementia. We calculated the summary pro- portion and absolute risk of dementia comparing subjects with and without the pathology. Results: We identified 10 studies comprising 2856 subjects. Vascular-type pathology and mixed pa- thology are respectively two and three times more likely in demented patients. The summary propor- tion of dementia is 77%–86% in subjects with mixed degenerative and vascular pathology and 45% in subjects with pure Alzheimer-type pathology.
    [Show full text]
  • International Innovation Professor Vladimir Hachinski
    A stroke of genius With over 600 scholarly articles and 23,000 citations to his name, Professor Vladimir Hachinski has been at the forefront of stroke, sudden death and vascular cognitive impairment research for the last 40 years PROFESSOR VLADIMIR PROFESSOR HACHINSKI In reality, vascular disease does not involve the and grow after the occurrence of stroke. brain to such an extent, and when dementia Similarly, inflammation is greater and flares. occurs it is often on the background of already Experimental treatment can suppress brain existing Alzheimer’s disease (AD). Thus, it is the changes and the cognitive consequences. co-occurrence and interaction of vascular disease and AD that is most commonly responsible for If we confirm this clinically, it will allow cognitive impairment in the elderly. Moreover, clinicians worldwide to use a joint the term vascular cognitive impairment can be treatment of anti-amyloid and anti- defined as any cognitive impairment caused by, or inflammatory agents to reduce the impact associated with, vascular factors. and mitigate the effects of stroke. It will also delay AD in those who might have This approach is promising as it emphasises become prone to it by the infarct. This has the one component that we can now treat and tremendous implications given that by the prevent, which is the vascular one. age of 73 around 50 per cent of the general population will have amyloid accumulations Another key area of your research is the within the brain. incidence of sudden death following stroke. Firstly, why does this occur, and secondly, why Our plans include a multidisciplinary attack are right-handed individuals more susceptible? on the problem.
    [Show full text]
  • Always Caring
    always caring 2006 REPORT TO THE COMMUNITY 1 3 London Health Sciences Centre (LHSC) is one of Canada’s largest acute care Message from the Chair of the Board of Directors page 1 teaching hospitals and is dedicated to excellence in patient care, teaching and research. 7 Message from the President and Chief Executive Officer page 3 LHSC has pioneered many national and international medical breakthroughs. Located in London, Ontario, LHSC encompasses three sites, South Street Hospital, University Message from the Chief of Staff page 7 Hospital and Victoria Hospital; two family medical centres; and the London Regional Message from the Chair of the Finance Committee page 9 Cancer Program. LHSC is the home of the Children’s Hospital of Western Ontario and CSTAR (Canadian Surgical Technologies & Advanced Robotics). The research arm 2005/2006 Activities and Statistics page 11 of LHSC is Lawson Health Research Institute, which is partnered with London’s other teaching hospital, St. Joseph’s Health Care, London. LHSC is affiliated with The University Always Moving Forward of Western Ontario. Physicians and staff at LHSC number close to 9,000 and together • June 12 hospital move page 13 9 they provided care for more than one million patient visits last year. Always Caring • New trauma unit puts patients at centre page 17 • Hospital researchers awarded major page 20 funding for breast cancer research • New program shortens hospital page 21 stay for hip and knee replacements 13 Always Innovating • Leading the way in diagnostic advancements page 22 • BRAINSAVE uses technology, partnerships page 24 to improve stroke treatment • Robotic assisted cardiac surgery is first in the world page 24 • Historic digital imaging network project page 25 brings care closer to home 17 Medical Breakthroughs page 26 On the cover: Nurse Sheila Ford cares for a patient in the new Critical Care Trauma Centre at LHSC Victoria Hospital.
    [Show full text]
  • Printable List of Laureates
    Laureates of the Canadian Medical Hall of Fame A E Maude Abbott MD* (1994) Connie J. Eaves PhD (2019) Albert Aguayo MD(2011) John Evans MD* (2000) Oswald Avery MD (2004) F B Ray Farquharson MD* (1998) Elizabeth Bagshaw MD* (2007) Hon. Sylvia Fedoruk MA* (2009) Sir Frederick Banting MD* (1994) William Feindel MD PhD* (2003) Henry Barnett MD* (1995) B. Brett Finlay PhD (2018) Murray Barr MD* (1998) C. Miller Fisher MD* (1998) Charles Beer PhD* (1997) James FitzGerald MD PhD* (2004) Bernard Belleau PhD* (2000) Claude Fortier MD* (1998) Philip B. Berger MD (2018) Terry Fox* (2012) Michel G. Bergeron MD (2017) Armand Frappier MD* (2012) Alan Bernstein PhD (2015) Clarke Fraser MD PhD* (2012) Charles H. Best MD PhD* (1994) Henry Friesen MD (2001) Norman Bethune MD* (1998) John Bienenstock MD (2011) G Wilfred G. Bigelow MD* (1997) William Gallie MD* (2001) Michael Bliss PhD* (2016) Jacques Genest MD* (1994) Roberta Bondar MD PhD (1998) Gustave Gingras MD* (1998) John Bradley MD* (2001) Phil Gold MD PhD (2010) Henri Breault MD* (1997) Richard G. Goldbloom MD (2017) G. Malcolm Brown PhD* (2000) Jean Gray MD (2020) John Symonds Lyon Browne MD PhD* (1994) Wilfred Grenfell MD* (1997) Alan Burton PhD* (2010) Gordon Guyatt MD (2016) C H G. Brock Chisholm MD (2019) Vladimir Hachinski MD (2018) Harvey Max Chochnov, MD PhD (2020) Antoine Hakim MD PhD (2013) Bruce Chown MD* (1995) Justice Emmett Hall* (2017) Michel Chrétien MD (2017) Judith G. Hall MD (2015) William A. Cochrane MD* (2010) Michael R. Hayden MD PhD (2017) May Cohen MD (2016) Donald O.
    [Show full text]
  • Dean's Report 2013
    The DEAN’S REPORT SCHULICH SCHOOL OF MEDICINE & DENTISTRY ANNUAL PERFORMANCE REVIEW | 2013 CONTENTS 03 A Message from Dr. Michael J. Strong 05 OPERATIONS & ADMINISTRATION 07 Space and Facilities 08 Finance 09 Human Resources 13 Alumni Relations and Development 15 OUTSTANDING EDUCATION 17 Program Offerings 18 Doctor of Medicine Program 20 Doctor of Medicine – Windsor Program 21 Distributed Medical Education 22 Postgraduate Medical Education 23 Doctor of Dental Surgery 26 Internationally Trained Dentists 27 Bachelor of Medical Sciences and Undergraduate Program in Neuroscience 29 Graduate and Postdoctoral Studies Office 30 Clinical Graduate Programs 31 Combined Degree Programs 33 CIHR Strategic Training Programs 34 Centre for Education Research & Innovation 35 Clinical Skills Learning Program 36 Continuing Professional Development 37 FINANCIAL ACCESSIBILITY 39 Scholarships, Awards and Bursaries 41 RESEARCH 43 Research Highlights 44 Research Funding 45 Notable Research Publications 46 Canada Research Chairs 47 Robarts Research Institute 49 AWARDS 59 INTERNATIONAL EFFORTS 63 SOCIAL RESPONSIBILITY THE DEAN’S REPORT | 2013 2 A MESSAGE FROM A MESSAGE FROM DR. MICHAEL J. STRONG 3 THE DEAN’S REPORT | 2013 The past year at the Schulich School of Medicine & Dentistry was one of action and celebration. Collectively, our School’s faculty and staff rolled up their sleeves to tackle some of the biggest initiatives and goals mapped out in our Strategic Plan. It was exciting and energizing to witness the plans come to fruition, and to celebrate our accomplishments which support our vision to become a global leader in optimizing life-long health through innovations in research, education and active engagement with our communities. The successful launch of our Master of Public Health Program was a major achievement for our School.
    [Show full text]
  • WORLD NEUROLOGY the Newsletter of the World Federation of Neurology
    WORLD NEUROLOGY The Newsletter of the World Federation of Neurology VOLUME 19, NUMBER 4, DECEMBER 2004 WORLD FEDERATION OF NEUROLOGY ELECTIONS NOMINATING COMMITTEE RECOMMENDATIONS The Nominating Committee of the World Federation of Neurology, having invited nominations for three Officer posts and one Trustee to be elected at the Council of Delegates Annual General Meeting (AGM) in November 2005 during the World Congress of Neurology, recom- mends to the membership those listed below as candidates in accordance with the Federation's Memorandum and Articles of Association. Recommended candidates: ! President (to take up office w.e.f. 1st January, 2006): Johan Aarli—Norway Destination Australia—XVIIIth World Congress of Neurology, Sydney, 2005 (Photograph of Jagjit Chopra—India Parliament at Canberra) Roger Rosenberg—USA ! First Vice President (to take up Candidates for President and First Vice At the time of writing, two candi- office w.e.f. 1st January, 2006): President will be required to formulate a dates—Prof. Leontino Battistin Vladimir Hachinski—Canada statement of their goals and objectives (Italy) and Prof. Julien Bogous- Theodore Munsat—USA for the organization, which will be pub- slavsky (Switzerland)—have been ! Secretary-Treasurer General lished. proposed under this regulation for (to take up office w.e.f. 1st January, the post of Secretary-Treasurer 2007): It is open to anyone to make additional General. Richard Kay—Hong Kong, SAR nominations by: China ! Securing the supporting signatures of Ra'ad Shakir—UK five or more authorized delegates ALSO IN THIS ISSUE: ! One Elected Trustee (to take up ! Submitting the name(s) of the individ- ! Editorial office w.e.f.
    [Show full text]
  • The Storied Career of the Storied Career Of
    WINTER 2013 UNIVERSITY OF TORONTO MEDICAL ALUMNI ASSOCIATION MAGAZINE MAAMATTERS The storied career of DR. JOE GREENBERG CONVOCATION 2013 • THE NEW FACE OF CPD PRESIDENT’S MESSAGE DR. PETER KOPPLIN (1963) Coincidence, connections and campaigns DR. LAURENCE LEE (1976), AN ALUMNUS you may be a bit confused by the plethora from BC, recently sent us a terrific letter. of email and mail requests for donations. He explained that a good number of years Some come directly from us; the MAA is a ago he addressed his son’s Grade 5 class as separate, registered charitable organization part of career day. Fast forward to 2013 from the Faculty. Other email requests and as Laurence is looking at the front come from the Faculty; it promotes the cover of the spring 2013 issue of MAA large U of T “Boundless” fundraising Matters, he recognizes one of those same campaign, supporting student aid, research Grade 5 kids—who is now a U of T senior and infrastructure. The MAA’s mission Meds student. While it would be a stretch focuses on student aid only and keeping to consider that the defining influence on alumni connected. the student’s career choice was Laurence’s As 2013 wanes, I am happy to remind talk, it was still, as Milan Kundera writes, you that you are a graduate of a great medical the “beauty” of coincidence. school and one that is growing even better. PHOTOGRAPHY: KEVIN KELLY PHOTOGRAPHY: Fostering relationships among alumni, I hope that you will continue to support students and the Faculty of Medicine is an the MAA as we continue to support our important part of the MAA mandate.
    [Show full text]
  • That Are Hoechst of All Field
    be a fraction of the asymptomatic vigabatrin-induced visual field defects that are unrecognized. At an international meeting in London, sponsored by Hoechst Marion Roussel, it was concluded that routine ophthalmological screening of all patients taking vigabatrin cannot be justified. Confrontational visual field examination is advised at baseline and follow-up of patients on vigabatrin, when practical. The risk:benefit ratio should be calculated for each individual, if visual field defects are uncovered. In infants receiving vigabatrin for the treatment of infantile spasms, the consensus argued that the benefits outweighed the risks. (Harding GFA. Benefit: risk ratio must be calculated for individual patients. BMI Jan 17, 1998;316:232-233). NONCONVULSIVE SEIZURES AND BRAIN DAMAGE Possible brain damage resulting from nonconvulsive seizures is debated "for" by Young GB and Jordan KG (Department of Clinical Neurological Sciences, 375 South St, London, Ontario, Canada N6A 4G5), and "against" by Aminoff MJ (Box 0114, Room M-794, Department of Neurology, School of Medicine, University of California, San Francisco, CA 94143). The brain damage school favors immediate and vigorous tratment of nonconvulsive status epilepticus (NCSE), whereas the non-damage group, while advocating treatment of NCSE, argues against potentially hazardous therapeutic extremes, such as general anesthesia. The section editor (Hachinski V) of these "Controversies in Neurology" concludes that both camps agree that brief absence seizures result in no detectable harm, though subtle cerebral changes may be difficult to detect. In balancing the potential harm of treatment compared with consequencies of nontreatment, antiepileptic side effects are usually transient, whereas sequelae of nontreatment may be cumulative and permanent.
    [Show full text]